BIOMAT Database Logo BIOMAT Database Logo

C99 selectively accumulates in vulnerable neurons in Alzheimer's disease. 2020

Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA.

The levels and distribution of amyloid deposits in the brain does not correlate well with Alzheimer's disease (AD) progression. Therefore, it is likely that amyloid precursor protein and its proteolytic fragments other than amyloid b (Ab) contribute to the onset of AD. We developed a sensitive assay adapted to the detection of C99, the direct precursor of b-amyloid. Three postmortem groups were studied: control with normal and stable cognition; patients with moderate AD, and individuals with severe AD. The amount of C99 and Aβ was quantified and correlated with the severity of AD. C99 accumulates in vulnerable neurons, and its levels correlate with the degree of cognitive impairment in patients suffering from AD. In contrast, Aβ levels are increased in both vulnerable and resistant brain areas. These results raise the possibility that C99, rather than Aβ plaques, is responsible for the death of nerve cells in AD.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001344 Autopsy Postmortem examination of the body. Autopsies,Post-Mortem Examination,Postmortem Examination,Examination, Post-Mortem,Examination, Postmortem,Examinations, Post-Mortem,Examinations, Postmortem,Post Mortem Examination,Post-Mortem Examinations,Postmortem Examinations
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.
February 2021, Nature neuroscience,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
February 2001, Neurobiology of disease,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
January 1993, Advances in neurology,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
[Advances in vulnerable mechanisms of selectively vulnerable neurons].
July 2005, Sheng li ke xue jin zhan [Progress in physiology],
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Embryonic development of selectively vulnerable neurons in Parkinson's disease.
January 2017, NPJ Parkinson's disease,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Microphysiology of selectively vulnerable neurons.
January 1985, Progress in brain research,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Neuromelanin-containing neurons are selectively vulnerable in parkinsonism.
October 1988, Trends in pharmacological sciences,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients.
April 2009, Brain pathology (Zurich, Switzerland),
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
NPC1-deficient neurons are selectively vulnerable for statin treatment.
June 2019, Neuropharmacology,
Maria V Pulina, and Maya Hopkins, and Vahram Haroutunian, and Paul Greengard, and Victor Bustos
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.
March 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!